Package 50742-430-01

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 50742-430-01
Digits Only 5074243001
Product NDC 50742-430
Description

1 VIAL in 1 CARTON (50742-430-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2019-09-25
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "9a017f89-25b4-4095-8a50-89ee1ee5267f", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0350742430017"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["b3a26585-e247-4b2e-a4ce-817b3aac2ff3"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (50742-430-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "50742-430-01", "marketing_start_date": "20190925"}], "brand_name": "DECITABINE", "product_id": "50742-430_9a017f89-25b4-4095-8a50-89ee1ee5267f", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "50742-430", "generic_name": "decitabine", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DECITABINE", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/1"}], "application_number": "ANDA210984", "marketing_category": "ANDA", "marketing_start_date": "20190925", "listing_expiration_date": "20261231"}